Efficacy of a pharmacist-managed diabetes clinic in high-risk diabetes patients, a randomized controlled trial-“Pharm-MD” Impact of clinical pharmacists in diabetes …

A Halalau, M Sonmez, A Uddin, P Karabon… - BMC Endocrine …, 2022 - Springer
Background Diabetes mellitus affects 13% of American adults. To address the complex care
requirements necessary to avoid diabetes-related morbidity, the American Diabetes …

Interprofessional collaboration in primary care for patients with chronic illness: a scoping review mapping leadership and followership

G Zhang, RE Stalmeijer, F Maulina, FWJM Smeenk… - BMJ …, 2024 - bmjleader.bmj.com
Background Effective interprofessional collaboration (IPC) in primary care is essential in
providing high-quality care for patients with chronic illness. However, the traditional role …

A 5-year trend in the use of sodium-glucose co-transporter 2 inhibitors and other oral antidiabetic drugs in a Middle Eastern country

N Zaghloul, A Awaisu, A Mahfouz, S Alyafei… - International Journal of …, 2022 - Springer
Background Sodium glucose co-transporter 2 inhibitors (SGLT2is) are a novel class of oral
antidiabetic drugs. To date, there are no pharmacoepidemiologic studies investigating the …

[PDF][PDF] Interprofessional relation models in type 2 diabetes mellitus: A systematic review

S Ma'rufah, NM Satibi, SA Kristina - Journal of Pharmacy & …, 2024 - jppres.com
Context: Diabetes mellitus is one of the biggest non-communicable disease problems
worldwide and 90% of diabetes cases are type 2 diabetes mellitus. This chronic disease …

Integration of clinical pharmacists to assist with medication surveillance for patients receiving gender-affirming hormone therapy in a community ambulatory setting …

E Stanger, AM Kehr, N McCorkindale, H Ng - Journal of the American …, 2024 - Elsevier
Background Gender-affirming care (GAC) for gender diverse individuals (includes
transgender and nonbinary persons) requires a comprehensive approach to medication …

[HTML][HTML] Assessing Type 2 Diabetes Risk in the Post-Pandemic Era: A Pharmacy-Led FINDRISC Screening Study

V Bell, AR Rodrigues, V Costa, C Dias, M Alpalhão… - Life, 2024 - mdpi.com
Diabetes mellitus (DM) is a major global health issue, with type 2 diabetes (T2D) accounting
for over 90% of cases. Community pharmacies, given their accessibility, are well positioned …

[HTML][HTML] Impacto de una unidad de farmacia de atención primaria en la optimización del tratamiento farmacológico de pacientes diabéticos tipo 2

L Canadell-Vilarrasa, T Palanques-Pastor… - Atención Primaria, 2024 - Elsevier
Objetivo Evaluar el impacto de una intervención farmacéutica en la optimización del
tratamiento de los pacientes con diabetes mellitus tipo 2. Diseño Estudio de intervención …

Impact of a primary care pharmacy unit on the optimization of pharmacological treatment of type 2 diabetic patients

L Canadell-Vilarrasa, T Palanques-Pastor… - Atencion …, 2024 - europepmc.org
[Impact of a primary care pharmacy unit on the optimization of pharmacological treatment of
type 2 diabetic patients]. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …

Personalized type 2 diabetes treatment in primary care: insights using real world data

M Ambrož - 2023 - research.rug.nl
The thesis focuses on personalized treatment among people with type 2 diabetes (T2D) in
primary care. Given recommendations for less strict glycated haemoglobin A1c (HbA1c) and …

Evidence on Real-World Data and Real-World Evidence As a Driver for Precision Medicine Implementation in Pharmacy Practice

R Hendricks-Sturrup, D Francis - … Health and Health Services Research in …, 2023 - Springer
Today, pharmacy and pharmaceutical professionals, including pharmacy students and
trainees, are highly encouraged to explore, contemplate, and understand the growing role …